Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 MicuRx Appoints Ge | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

MicuRx Appoints Ge

Responsible for development of anti-infective program

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

James Ge, M.D., Ph.D. has been named executive vice president, chief operations and development officer responsible for global development at MicuRx. Dr. Ge has broad experience in all areas of anti-infective drug development, from discovery through international regulatory approvals.

Prior to MicuRx, he served in a variety of executive and escalating management positions at pharmaceutical and biotechnology companies including ALDEA Pharmaceuticals, Kalidex Pharmaceuticals, Calixa Pharmaceuticals (acquired by Cubist Pharmaceuticals), Forest Laboratories, Cerexa Pharmaceuticals (acquired by Forest Laboratories), Peninsula Pharmaceuticals (acquired by J&J Pharmaceuticals), Genesoft Inc, and Magainin Pharmaceuticals Inc. He has founded or co-founded several biotech franchises, and played a key role in the growth and exit of three antibiotics companies.

Zhengyu Yuan, Ph.D., president and chief executive officer of MicuRx, commented, “The addition of James Ge to our executive management team brings premier industry leadership into our clinical studies and international operations, and we look forward to relying on his insight and direction to ensure accelerated progress of MRX-I clinical studies.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics